Sergiusz Markowicz

965 total citations
30 papers, 757 citations indexed

About

Sergiusz Markowicz is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sergiusz Markowicz has authored 30 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Immunology and 9 papers in Oncology. Recurrent topics in Sergiusz Markowicz's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (8 papers) and Cancer Cells and Metastasis (5 papers). Sergiusz Markowicz is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (8 papers) and Cancer Cells and Metastasis (5 papers). Sergiusz Markowicz collaborates with scholars based in Poland, United States and Hungary. Sergiusz Markowicz's co-authors include Edgar G. Engleman, Elżbieta Katarzyna Jagusztyn-Krynicka, Monika Adamczyk-Popławska, Magdalena Kowalewska, Magdalena Chechlińska, Radosława Nowak, Paulina Kober, Emilia Białopiotrowicz, Monika Prochorec‐Sobieszek and Patryk Górniak and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Sergiusz Markowicz

29 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergiusz Markowicz Poland 12 500 233 229 76 64 30 757
Orsalem J. Kahsai United States 5 581 1.2× 218 0.9× 326 1.4× 69 0.9× 97 1.5× 11 873
Thi Migone United States 7 594 1.2× 141 0.6× 209 0.9× 67 0.9× 84 1.3× 13 896
Till A. Röhn Switzerland 14 549 1.1× 271 1.2× 112 0.5× 55 0.7× 90 1.4× 20 860
Ryuta Mukasa Japan 7 912 1.8× 221 0.9× 184 0.8× 55 0.7× 77 1.2× 11 1.1k
Maryaline Coffre United States 14 516 1.0× 235 1.0× 314 1.4× 40 0.5× 62 1.0× 19 834
Todd A. Braciak Germany 16 274 0.5× 154 0.7× 196 0.9× 51 0.7× 46 0.7× 32 625
Seema Rawal United States 8 889 1.8× 126 0.5× 187 0.8× 143 1.9× 42 0.7× 17 1.1k
Hart S. Dengler United States 7 448 0.9× 249 1.1× 101 0.4× 39 0.5× 31 0.5× 7 666
Laurence Goffin Switzerland 15 330 0.7× 261 1.1× 96 0.4× 65 0.9× 74 1.2× 26 723
Shengwu Liu China 14 276 0.6× 268 1.2× 312 1.4× 41 0.5× 59 0.9× 23 677

Countries citing papers authored by Sergiusz Markowicz

Since Specialization
Citations

This map shows the geographic impact of Sergiusz Markowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergiusz Markowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergiusz Markowicz more than expected).

Fields of papers citing papers by Sergiusz Markowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergiusz Markowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergiusz Markowicz. The network helps show where Sergiusz Markowicz may publish in the future.

Co-authorship network of co-authors of Sergiusz Markowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Sergiusz Markowicz. A scholar is included among the top collaborators of Sergiusz Markowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergiusz Markowicz. Sergiusz Markowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, William, et al.. (2025). Cancer cells accelerate exhaustion of persistently activated mouse CD4 + T cells. OncoImmunology. 14(1). 2521392–2521392. 3 indexed citations
2.
Paszkiewicz‐Kozik, Ewa, Sergiusz Markowicz, Jan Walewski, et al.. (2023). New molecular targets in Hodgkin and Reed-Sternberg cells. Frontiers in Immunology. 14. 7 indexed citations
3.
4.
Polak, Anna, Maciej Szydłowski, Ewa Jabłońska, et al.. (2016). MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy. PLoS ONE. 11(5). e0155893–e0155893. 25 indexed citations
5.
Szczepek, Wojciech J., et al.. (2016). Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin. Archivum Immunologiae et Therapiae Experimentalis. 65(1). 51–67. 7 indexed citations
6.
Kutner, Andrzej, et al.. (2016). The Effect of Analogues of 1α,25-Dihydroxyvitamin D2 on the Regrowth and Gene Expression of Human Colon Cancer Cells Refractory to 5-Fluorouracil. International Journal of Molecular Sciences. 17(6). 903–903. 12 indexed citations
7.
Bujko, Mateusz, et al.. (2016). Human regulatory T cells suppress proliferation of B lymphoma cells. Leukemia & lymphoma. 57(8). 1903–1920. 13 indexed citations
8.
Szydłowski, Maciej, Ewa Jabłońska, Emilia Białopiotrowicz, et al.. (2015). FOXO1 Activation Is an Effector of SYK and AKT Inhibition in Tonic BCR Signal-Dependent Diffuse Large B-Cell Lymphomas. Blood. 126(23). 314–314. 3 indexed citations
9.
Szydłowski, Maciej, Emilia Białopiotrowicz, Ewa Jabłońska, et al.. (2015). FOXO1-p300-Txn Circuit Regulates Oxidative Stress Responses in Diffuse Large B-Cell Lymphomas Characterized By Enhanced Oxidative Phosphorylation. Blood. 126(23). 466–466.
10.
11.
Markowicz, Sergiusz, et al.. (2014). Anticancer Properties of Peptide Fragments of Hair Proteins. PLoS ONE. 9(6). e98073–e98073. 4 indexed citations
12.
Skurzak, H, Sergiusz Markowicz, Anna Leśniak, et al.. (2013). Original article Opioid agonist – tachykinin antagonist as a new analgesic with adjuvant anticancer properties. Folia Neuropathologica. 2(2). 132–139. 11 indexed citations
13.
Markowicz, Sergiusz, Zbigniew Nowecki, Piotr Rutkowski, et al.. (2012). Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients. Medical Oncology. 29(4). 2966–2977. 17 indexed citations
14.
Adamczyk-Popławska, Monika, Sergiusz Markowicz, & Elżbieta Katarzyna Jagusztyn-Krynicka. (2011). Proteomics for development of vaccine. Journal of Proteomics. 74(12). 2596–2616. 38 indexed citations
15.
Markowicz, Sergiusz, Zbigniew Nowecki, Piotr Rutkowski, et al.. (2009). Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients. Journal of Clinical Oncology. 27(15_suppl). 9039–9039. 1 indexed citations
16.
Markowicz, Sergiusz, Jan Walewski, Paweł Wiechno, et al.. (2002). Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy. PubMed. 7(1). 15–24. 6 indexed citations
17.
Markowicz, Sergiusz, Jan Walewski, & Andrzej Kawecki. (1995). Isolation and Characteristics of Dendritic Cell Progenitors from the Bone Marrow of the Hodgkin’s Disease Patients. Advances in experimental medicine and biology. 378. 553–555. 1 indexed citations
18.
Markowicz, Sergiusz, et al.. (1994). Generation of antigen-specific CD8+ CTLs from naive precursors.. The Journal of Immunology. 153(3). 996–1003. 127 indexed citations
19.
Markowicz, Sergiusz, et al.. (1993). The Effect of Human Dendritic Cells on the Lectin-Induced Responsiveness of CD4+ T Cells To IL-2 and IL-4. Advances in experimental medicine and biology. 329. 75–80. 2 indexed citations
20.
Markowicz, Sergiusz & Edgar G. Engleman. (1990). Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.. Journal of Clinical Investigation. 85(3). 955–961. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orsalem J. Kahsai Breakdown of academic impact, for papers by Thi Migone Breakdown of academic impact, for papers by Till A. Röhn Breakdown of academic impact, for papers by Ryuta Mukasa Breakdown of academic impact, for papers by Maryaline Coffre Breakdown of academic impact, for papers by Todd A. Braciak Breakdown of academic impact, for papers by Seema Rawal Breakdown of academic impact, for papers by Hart S. Dengler Breakdown of academic impact, for papers by Laurence Goffin Breakdown of academic impact, for papers by Shengwu Liu
Rankless by CCL
2026